Crucial Identification Of Cancer Advancing AEG-1 Gene

Researchers from the Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine have discovered a gene that dons central role in two processes which are critical for the tumor to develop, grow and progress to metastasis. Scientists are hopeful that this discovery would aid in leading to an effectual therapy for targeting and restraining the expression of this gene that would result in hampering cancer growth.

The team of researchers have revealed that astrocyte promoted gene-1, AEG-1; a cancer encouraging gene has a decisive role in both oncogenic alteration of a healthy cell into a cancerous one, and angiogenesis that is the development of novel blood cells. Oncogenic change and angiogenesis are essential for the tumor to develop, grow and progress to metastasis.

The study which was printed online during the week of November 16 in the Early Edition of the journal Proceedings of the National Academy of Sciences, researchers employed a string of molecular researches wherein they reported that high expression of AEG-1 is majorly involved in transforming normal cells into malignant ones.

Fisher explicated that when there was AEG-1 expression in normal immortal rat embryo fibroblast cells it transformed these cells into altered cells that were observed to induce swiftly proliferating belligerent cancers when infused into animals. AEG-1 expressing cells exhibited increased expression of genes that regulated blood vessel development, thus turning major contributors to tumorigenicity. The team had additionally identified the access ways in target cells that are triggered by AEG-1 and arbitrate its oncogenic and angiogenic provoking properties.

The goal of the researchers was to comprehend the functions of a new-fangled gene AEG-1 that dons a critical role in tumor development, with the prospective of developing effectual remedial approaches for numerous cancers via targeted reticence of this new-fangled molecule or its downstream adjusted processes.

The scientists believe that this identification would pave the course for amelioration of the anguish faced by cancer patients by discovering novel and effectual possibilities for treatment.

For expansion of the research work conducted on AEG-1, the VCU Department of Human and Molecular Genetics, Institute of Molecular Medicine and Massey Cancer Center lately attained the National Cancer Institute grant summing up to 1.6 million dollars for studying the AEG-1 gene in the perspective of malignant brain tumors like glioblastoma multiforme or GBM. Paul B. Fisher, M.Ph., Ph.D., who is the primary researcher for the study mentioned that the study would broaden the understanding of this gene and the manner in which it would function as an oncogenic or altering gene.

Fisher explicated that cancer progress are multi factor and step processes that arise in a temporal way. As stated earlier, AEG-1 evidently has manifold roles in diverse steps of tumor development, inclusive of tumor cell expansion, insensitivity to growth-inhibitory indicators, inclusive chemotherapeutic agents, incursion, angiogenesis and metastasis.

Additionally, AEG-1 has been observed to don oncogenic roles in numerous cancers inclusive of glioma (CNS tumor), neuroblastoma, liver cancer, breast cancer, prostate cancer, lung cancer and esophageal squamous cell carcinoma. These vital associations make this gene a captivating molecule to research with potential for serving as a direct target for cancer therapy.

Popularity: 2% [?]